目录产品 » IL-7R alpha/CD127 hFc Chimera, Human
Manual
SDS
COAs

IL-7R alpha/CD127 hFc Chimera, Human

Interleukin 7 (IL-7) and its receptor (IL-7R, a heterodimer of IL-7Rα and γc) are essential for normal lymphoid development. IL-7 and IL-7R activate three main pathways: STAT5, PI3K/Akt/mTOR and MEK/Erk, ultimately leading to the promotion of leukemia cell viability, cell cycle progression and growth.
￥2500
Z05514-100

产品简介
Species Human
Protein Construction
IL-7 R alpha/CD127 (Glu21-Gly236)
Accession # P16871-1		 hFc
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Immobilized Human IL­7 at 2μg/ml (100μl/Well) on the plate can bind IL-7R alpha/CD127 hFc Chimera, Human. Test result was comparable to standard batch
Expression System HEK293
Theoretical Molecular Weight 51.6 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 65-75 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.
返回

技术背景
Target Background Interleukin 7 (IL-7) and its receptor (IL-7R, a heterodimer of IL-7Rα and γc) are essential for normal lymphoid development. IL-7 and IL-7R activate three main pathways: STAT5, PI3K/Akt/mTOR and MEK/Erk, ultimately leading to the promotion of leukemia cell viability, cell cycle progression and growth.
Synonyms IL-7R alpha; IL7Ra; CD127; CDW127; IL7Rα
返回

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.